Kelly Coller

Title: Innovator Spotlight: Kelly Coller

Introduction: Kelly Coller is a notable inventor based in Abbott Park, Illinois. With a focus on advancements in medical diagnostics, he has made significant contributions to the detection of human pegivirus 2 (HPgV-2). He holds a total of three patents which reflect his innovative approach towards healthcare solutions.

Latest Patents: One of Kelly Coller's latest patents includes "Compositions and methods for detecting human pegivirus 2 (HPgV-2)." This invention provides compositions, methods, and kits designed for the detection of HPgV-2. Notable elements of this patent are specific nucleic acid probes and primers aimed at detecting HPgV-2 nucleic acid. It also explores immunogenic compositions, treatment methods utilizing HPgV-2 peptides, and innovative methods for detecting HPgV-2 subject antibodies in various samples. His work in this area demonstrates a commitment to improving patient diagnostics and treatment responses.

Career Highlights: Kelly has contributed his expertise in prestigious organizations, notably Abbott Laboratories Corporation and the University of California. His role in these organizations allowed him to pursue groundbreaking research and development projects that bridge the gap between science and practical healthcare solutions.

Collaborations: Throughout his career, Kelly has worked alongside esteemed colleagues, including Charles Chiu and Deanna Lee. These collaborations have fostered an environment of creativity and innovation, propelling significant advancements in their shared fields of research.

Conclusion: Kelly Coller's work exemplifies the spirit of innovation in the medical field. His dedication to enhancing diagnostic methods for human pegivirus 2 not only showcases his inventive prowess but also contributes to the broader goal of improving healthcare outcomes. With multiple patents to his name, Kelly continues to be an influential figure in the world of medical innovations.